Connor Clark & Lunn Investment Management Ltd. acquired a new position in AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 9,414 shares of the insurance provider's stock, valued at approximately $485,000.
Other large investors also recently modified their holdings of the company. Isthmus Partners LLC raised its position in AMERISAFE by 0.5% in the 4th quarter. Isthmus Partners LLC now owns 63,926 shares of the insurance provider's stock valued at $3,295,000 after buying an additional 316 shares during the last quarter. Amundi grew its stake in shares of AMERISAFE by 169.2% in the 4th quarter. Amundi now owns 9,210 shares of the insurance provider's stock worth $456,000 after acquiring an additional 5,789 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in shares of AMERISAFE in the fourth quarter valued at about $9,708,000. Charles Schwab Investment Management Inc. raised its holdings in shares of AMERISAFE by 3.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 661,795 shares of the insurance provider's stock valued at $34,109,000 after purchasing an additional 21,799 shares during the last quarter. Finally, Versor Investments LP bought a new position in shares of AMERISAFE during the fourth quarter valued at about $205,000. Institutional investors own 97.41% of the company's stock.
AMERISAFE Stock Performance
NASDAQ:AMSF traded up $0.49 on Wednesday, hitting $52.51. The stock had a trading volume of 87,982 shares, compared to its average volume of 106,263. AMERISAFE, Inc. has a 1 year low of $41.97 and a 1 year high of $60.24. The firm's fifty day simple moving average is $50.62 and its two-hundred day simple moving average is $51.98. The stock has a market cap of $1.00 billion, a P/E ratio of 16.41 and a beta of 0.33.
AMERISAFE (NASDAQ:AMSF - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The insurance provider reported $0.67 EPS for the quarter, beating analysts' consensus estimates of $0.60 by $0.07. AMERISAFE had a return on equity of 16.50% and a net margin of 19.49%. The company had revenue of $73.51 million during the quarter, compared to the consensus estimate of $77.37 million. Equities research analysts predict that AMERISAFE, Inc. will post 2.45 EPS for the current year.
AMERISAFE Cuts Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Friday, March 7th were issued a dividend of $0.39 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.56 dividend on an annualized basis and a yield of 2.97%. AMERISAFE's dividend payout ratio (DPR) is presently 53.98%.
AMERISAFE Profile
(
Free Report)
AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Further Reading

Before you consider AMERISAFE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.
While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.